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The complex process of apoptosis is orchestrated by caspases, a family of cysteine proteases with 
unique substrate specificities. Accumulating evidence suggests that cell death pathways are finely 
tuned by multiple signaling events, including direct phosphorylation of caspases, whereas kinases 
are often substrates of active caspases. Importantly, caspase-mediated cleavage of kinases can 
terminate prosurvival signaling or generate proapoptotic peptide fragments that help to execute 
the death program and facilitate packaging of the dying cells. Here, we review caspases as kinase 
substrates and kinases as caspase substrates and discuss how the balance between cell survival 
and cell death can be shifted through crosstalk between these two enzyme families.Apoptosis is a form of programmed cell death characterized 
by distinct morphological changes that include cell rounding, 
membrane blebbing, cytoskeletal disassembly, chromatin con-
densation, and DNA fragmentation (Kroemer et al., 2008). These 
dramatic cellular alterations, which allow for packaging of the 
dying cell and its subsequent engulfment by neighboring cells or 
phagocytes, can be ascribed to the actions of caspases, a fam-
ily of cysteinyl aspartate-directed proteases that cleave a wide 
range of cellular proteins (for a compiled list of published cas-
pase substrates, refer to the CASBAH online database http://
bioinf.gen.tcd.ie/casbah/) (Lüthi and Martin, 2007). Although the 
cleavage of many caspase substrates is required for the struc-838 Cell 138, September 4, 2009 ©2009 Elsevier Inc.tural packaging of cellular contents during apoptosis, a subset 
of caspase substrates are signaling molecules whose cleavage 
alters their signaling properties to affect the internal environ-
ment of the dying cell. In turn, signaling molecules can modulate 
caspase function to positively or negatively alter the trajectory 
of the cell death program. Given the millions of reversible phos-
phorylation events necessary to maintain cellular homeostasis 
and to allow cells to adapt nimbly to changing internal and exter-
nal environments, the bidirectional communication between 
caspases and the kinases/phosphatases that control the cel-
lular phosphoproteome is of particular interest. This Review 
will consider the impact of caspase cleavage on kinase/phos-Figure 1. Extrinsic and Intrinsic Apoptotic 
Pathways
Three major apoptotic pathways, initiated by 
the apical caspase-2, -9, and -8/10, are de-
picted. In the extrinsic pathway of apoptosis, 
caspase-8 (or caspase-10) is activated upon 
the binding of a cognate ligand such as Fas li-
gand through the formation of the death-induc-
ing signaling complex (DISC), which includes a 
death receptor (for example, Fas) and a death 
domain-containing adaptor protein (for exam-
ple, Fas-associated death domain or FADD). 
Once active, caspase-8 directly cleaves and 
activates executioner caspases (for example, 
caspase-3) and/or the BH3-only protein Bid, 
which activates the intrinsic apoptotic path-
way by triggering oligomerization (activation) of 
the proapoptotic proteins Bax and Bak. Bax/
Bak activation is promoted by cleaved Bid 
(tBid), as well as other BH3-only proteins; the 
antiapoptotic Bcl-2 family members regulate 
the inhibition of Bax/Bak. The intrinsic path-
way leads to the release of cytochrome c from 
the intermembrane space of the mitochondria 
to the cytoplasm. Binding of cytochrome c in-
duces oligomerization of the adaptor protein 
Apaf-1, which recruits and activates caspase-9 
(through formation of the apoptosome), lead-
ing to activation of executioner caspases. Cas-
pase-2 is activated through the PIDDosome, 
which consists of the two adaptor proteins, 
PIDD (p53-induced protein with a death domain) and RAIDD (RIP-associated ICH-1/CED-3 homologous protein with a death domain). Only a few 
direct caspase-2 substrates have been identified, and apoptotic pathways induced by the activation of caspase-2 appear to be mediated at least in 
part by the cleavage of Bid.
phatase function, the ways in which phosphorylation can alter 
both caspases and their potential substrates, and the ways in 
which these classes of signaling molecules are linked to control 
cell death and survival.
Triggering Caspase Activation
Caspases are synthesized as inert zymogens whose activation 
is triggered by a diverse array of internal and external cues 
(reviewed in Li and Yuan, 2008). Upon receipt of apoptotic stim-
uli, cells activate initiator caspases (for example, caspase-2, 
-8, -9, and -10) that, in turn, proteolytically cleave and activate 
effector (also called executioner) caspases (for example, cas-
pase-3, -6, and -7). Once active, effector caspases proteolyti-
cally cleave a range of substrates, leading to the dismantling of 
the dying cell (Fischer et al., 2003).
Procaspases contain an N-terminal prodomain, as well as 
sequences encoding the large (p20) and small (p10) subunits of 
the mature protease. The initiator caspases are characterized by 
long prodomains that serve as platforms for the recruitment of 
activating adaptor proteins. The prodomains of caspase-2 and 
-9 contain a caspase recruitment domain (CARD), whereas cas-
pase-8 and -10 possess two tandem repeats of the death effector 
domain (DED). In either case, these domains interact homotypi-
cally with adaptors that promote caspase activation through a 
mechanism of induced proximity, wherein the close juxtaposition 
of two caspase molecules leads to the formation of an active cas-
pase tetramer containing two small and two large subunits.
Activation of the initiator caspases may occur through either 
an extrinsic or an intrinsic pathway (reviewed in Danial and Kors-
meyer, 2004). In the extrinsic pathway, engagement of cognate 
ligands with death receptors (for example, Fas) induces recep-
tor trimerization and subsequent recruitment of death domain 
(DD)-containing adaptor proteins, such as Fas-associated death 
domain (FADD), to corresponding death domain motifs on a cyto-
plasmic region of the death receptors. The resulting death-induc-
ing signaling complex (DISC), in turn, recruits, oligomerizes, and 
thereby activates zymogenic caspase-8 (or caspase-10) through 
homotypic interactions between the death effector domain 
within the caspase and the related death effector domain within 
the adaptor protein. Active caspase-8 can directly cleave and 
activate the effector caspases (for example, caspase-3) and/
or engage the intrinsic apoptotic pathway through cleavage of 
the Bcl-2 homology 3 (BH3)-only protein Bid. Cleaved Bid (tBid) 
translocates to the mitochondria, where it triggers activation of 
the intrinsic apoptotic pathway by promoting activation of the 
Bcl-2 proteins Bax and Bak, which induces mitochondrial outer 
membrane permeabilization (MOMP) and release of proapop-
totic mitochondrial constituents into the cytoplasm (Figure 1).
The cellular decision to initiate apoptosis in the intrinsic path-
way reflects a balance between proapoptotic and prosurvival 
Bcl-2 family proteins (reviewed in Chipuk and Green, 2008). Clas-
sified based on blocks of sequence homology, the proapoptotic 
Bcl-2 family members are subdivided into BH3-only proteins 
(for example, Bim, Bid, and Bad) and multidomain proteins (for 
example, Bax and Bak) that contain various blocks of homology. 
In response to apoptotic stimuli (such as DNA damage), BH3-
only proteins are activated and, directly or indirectly, promote oli-
gomerization of Bax/Bak, permeabilization of the mitochondrial outer membrane, and release of factors from the intermembrane 
space of the mitochondria (most notably cytochrome c). Prosur-
vival Bcl-2 family members (for example, Bcl-2, Bcl-XL, and Mcl-1) 
counteract this effect by sequestering proapoptotic family mem-
bers. Once in the cytoplasm, cytochrome c promotes oligomer-
ization of the caspase recruitment domain-containing adaptor 
protein Apaf-1. Heptameric Apaf-1 recruits the zymogenic form 
of caspase-9 through a CARD-CARD interaction and forms the 
apoptosome, which leads to dimerization-induced activation of 
caspase-9. Caspase-9 in turn cleaves effector caspases, leading 
directly to their activation (Figure 1).
The molecular mechanisms leading to activation of cas-
pase-2 remain somewhat elusive. However, various lines of 
evidence have placed it upstream of the mitochondria in the 
intrinsic pathway, as it is known to cleave and activate the 
latent proapoptotic activity of Bid (Bonzon et al., 2006). A cur-
rent model suggests that a p53-inducible adaptor protein, 
PIDD (p53-induced protein with a death domain), is induced 
in response to certain apoptotic stimuli, such as DNA damage. 
PIDD then engages a second adaptor protein, RAIDD (RIP-
associated ICH-1/CED-3 homologous protein with a death 
domain), resulting in the recruitment of caspase-2 through a 
CARD-CARD interaction and the formation of the “PIDDosome” 
(a structure that is analogous to the apoptosome), where cas-
pase-2 dimerizes and is activated (Figure 1). By virtue of being 
at the apex of an apoptotic pathway, caspase-2 is classified as 
an initiator caspase. Yet, it does not appear to directly activate 
any effector caspases. Moreover, caspase-2 seems to prefer-
entially recognize five amino acid residues within substrates, 
rather than four residues, the typical recognition motif for other 
caspases. Only a few bona fide caspase-2 substrates, other 
than Bid, have been identified and validated (for review, see 
Krumschnabel et al., 2009).
Caspases as Kinase Targets
Although the adaptor protein-mediated activation process 
described above provides a good measure of control over cas-
pase activity within cells, it has become increasingly clear that 
these activities can be finely tuned through additional binding 
partners (for example, inhibitor of apoptosis [IAP] proteins) 
and posttranslational modifications (for example, nitrosylation, 
phosphorylation, and ubiquitination). With respect to phos-
phorylation, both the caspase activation process and intrinsic 
enzymatic activity are under the control of modifying kinases 
and phosphatases (Table 1). This permits cellular flexibility in 
setting a threshold for the induction of apoptosis in response 
to alterations in the cellular environment (for example, after 
growth factor stimulation or changes in cellular metabolism) 
through changes in the activity of pro- or antiapoptotic kinases 
and phosphatases. Phosphorylation may also control caspase 
activity indirectly by controlling other apoptotic modulators 
(including caspase binding partners). Here, we consider con-
trol of caspases that can be exerted via their direct phospho-
rylation (Table 1).
Caspase-9
Inhibition of caspase-9 may result in the failure of apoptotic 
induction even when cytochrome c has been released from the 
mitochondria. Indeed, protection from apoptosis despite cyto-Cell 138, September 4, 2009 ©2009 Elsevier Inc. 839
Table 1. Modulation of Caspase Activity by Phosphorylation
Caspase Kinase/Phosphatase Sites Outcomes of Phosphorylation
Caspase-2 DNA-PK serine 122 (serine 139) Caspase activation
Caspase-2 CaMKII serine 135 (Xenopus), serine 164 (Human, mouse) Suppression of caspase activity
Caspase-2 PP1 serine 135 (Xenopus), serine 164 (Human, mouse) Suppression of caspase activity
Caspase-2 CK2 serine 157 Suppression of caspase activity
Caspase-3 PKCδ ND Enhancement of caspase activity
Caspase-3 p38 MAPK serine 150 Suppression of caspase activity
Caspase-3 PP2A serine 150 Suppression of caspase activity
Capsase-8 ND tyrosine 310 (tyrosine 293) SHP1 binding
Capsase-8 Src, Fyn, Lyn tyrosine 397 (tyrosine 380) Suppression of caspase activity
Capsase-8 SHP1 tyrosine 397 (tyrosine 380) Suppression of caspase activity
Capsase-8 Lyn tyrosine 465 (tyrosine 448) Suppression of caspase activity
Capsase-8 SHP1 tyrosine 465 (tyrosine 448) Suppression of caspase activity
Capsase-8 p38 MAPK serine 364 (serine 347) Suppression of caspase activity
Caspase-9 ERK1/2 threonine 125 Suppression of caspase activity
Caspase-9 CDK1 threonine 125 Suppression of caspase activity
Caspase-9 DYRK1A threonine 125 Suppression of caspase activity
Caspase-9 p38 MAPK threonine 125 Suppression of caspase activity
Caspase-9 PP1α threonine 125 Suppression of caspase activity
Caspase-9 PKCζ serine 144 Suppression of caspase activity
Caspase-9 c-Abl tyrosine 153 Enhancement of caspase activity
Caspase-9 PKA serine 99, serine 183, serine 195 No effect 
Caspase-9 Akt serine 196 (Human) Suppression of caspase activity
Caspase-9 CK2 serine 348 (Mouse, not conserved in humans) Protection from caspase-8 cleavage
Various phosphorylation sites have been identified on caspases that can regulate their activity. Calcium/calmodulin-dependent protein kinase II 
(CaMKII) and casein kinase 2 (CK2) phosphorylate caspase-2 at their respective sites and inhibit activation. DNA-dependent protein kinase (DNA-
PK) phosphorylates and activates caspase-2 in the nucleus, which triggers the DNA-damage checkpoint and subsequent DNA repair rather than 
apoptosis (note that the originally identified serine 122 site on caspase-2 corresponds to serine 139 in the most updated protein sequence [NCBI 
reference sequence: NP_116764.2]). p38 mitogen-activated protein kinase (MAPK) phosphorylation of caspase-3 is inhibitory, whereas phosphoryla-
tion by PKCδ enhances the activity of caspase-3 (note that the PKCδ phosphorylation site on caspase-3 has yet to be determined [ND]). The serine 
150 phosphorylation site on caspase-3 appears to be conserved in other caspases, as p38 MAPK also phosphorylates serine 364 of caspase-8, the 
homologous residue to serine 150 of caspase-3. Phosphorylation sites on caspase-8 have been identified in the A isoform (also known as α-4) as well 
as in the B isoform (α-1); the difference in protein sequence between the two isoforms is only observed in their prodomains. The phosphorylation sites 
in the B isoform are indicated in parentheses. The Src family tyrosine kinases, as well as p38 MAPK, suppress caspase-8 activity by phosphorylating 
the indicated amino acid residues. Phosphorylation at tyrosine 397 (380) has also been implicated in capsapse-8-mediated cell motility. The kinase 
that targets tyrosine 310 (293) on caspase-8, which provides a docking site for Src-homology domain 2 (SH2)-containing tyrosine phosphatase 1 
(SHP1), has not been determined (ND). Caspase-9 has been found to be a target of several different kinases. Of note, protein kinase A (PKA) appears 
to inhibit caspase-9 activation in response to mitochondrial cytochrome c release. Although three sites were identified as direct PKA phosphorylation 
sites on caspase-9 (Martin et al., 2005), mutation of these sites to a nonphosphorylatable form (alanine) has no effect on PKA-mediated inhibition of 
caspase-9 activation. Thus, the relevant PKA substrate that limits caspase-9 activation downstream of mitochondrial cytochrome c release remains 
elusive. Note that unless otherwise stated, the phosphorylation sites shown in Table 1 denote the amino acid numbers in human proteins.chrome c release has been described, although such protec-
tion has been attributed only in part to caspase-9 inactivation 
(reviewed in Schafer and Kornbluth, 2006). The first report of 
caspase phosphorylation demonstrated that human caspase-9 
could be phosphorylated by the prosurvival kinase Akt at ser-
ine 196 (S196) and thereby inhibited (Cardone et al., 1998). 
The universality of this finding was subsequently questioned 
when it was noted that S196 is not conserved in all species (for 
example, in mouse and dog) and that mouse caspase-9 is not 
demonstrably phosphorylated by Akt (Fujita et al., 1999).
Perhaps the most extensively characterized and function-
ally validated phosphorylation site on caspase-9 lies within 
its prodomain at threonine 125 (T125). This site is phospho-
rylated by both Erk (extracellular signal-regulated kinase) and 840 Cell 138, September 4, 2009 ©2009 Elsevier Inc.Cdk1 (cyclin-dependent kinase 1), and this phosphorylation 
suppresses caspase-9 activation (Allan et al., 2003; Allan and 
Clarke, 2007). Given that the Erk pathway is upregulated in a 
variety of cancers, this inhibitory phosphorylation of caspase-9 
may contribute to apoptotic (and therefore chemotherapeu-
tic) resistance. Suppression of caspase-9 by Cdk1-mediated 
phosphorylation of T125 has been shown to forestall cell death 
during mitosis, though the physiological necessity for such 
inhibition has not been adequately explained (for review, see 
Clarke and Allan, 2009). One interesting possibility is that the 
rounding of cell shape at mitosis results in a loss of contact 
with neighboring cells and would trigger detachment-induced 
cell death (anoikis) without the inhibition of caspase-9. Addi-
tional kinases—DYRK1A (dual-specificity tyrosine-(Y)-phos-
phorylation-regulated kinase A1) and p38 mitogen-activated 
protein kinase (p38 MAPK)—also phosphorylate T125 (Laguna 
et al., 2008; Seifert et al., 2008; Seifert and Clarke, 2009), and a 
recent study has shown that DYRK1A protects retinal cells from 
death during neuronal development (Laguna et al., 2008).
Given that T125 is a target of multiple kinases, it is important 
to determine how dephosphorylation of this site is regulated. 
With an interleukin-2 (IL-2)-dependent mouse T cell line, ser-
ine/threonine protein phosphatase 1α (PP1α) was shown to be 
the relevant phosphatase for dephosphorylation of T125 and 
activation of caspase-9 after IL-2 deprivation (Dessauge et al., 
2006). It will be interesting to determine whether PP1α plays a 
role in the regulation of caspase-9 in other cell types, particu-
larly in human tumor cells. Caspase-9 has also been described 
as a substrate of c-Abl, protein kinase Cζ (PKCζ), and casein 
kinase 2 (CK2), which phosphorylate it at tyrosine 153 (Y153), 
serine 144 (S144), and serine 348 (S348), respectively (although 
CK2 does not phosphorylate human caspase-9, which lacks 
a CK2 consensus site) (Brady et al., 2005; McDonnell et al., 
2008; Raina et al., 2005). Phosphorylation of Y153 is induced 
upon DNA damage and reportedly enhances caspase-9 activ-
ity, whereas PKCζ phosphorylation is triggered in response to 
osmotic stress and suppresses caspase activity (Table 1).
Caspase-2
The most evolutionarily conserved caspase, caspase-2, is 
a substrate of CK2, calcium/calmodulin-dependent protein 
kinase type II (CaMKII), and DNA-dependent protein kinase 
(DNA-PK). CK2 phosphorylates caspase-2 at serine 157 (S157) 
in the region connecting the caspase recruitment domain and 
the large subunit, blocking the dimerization and subsequent 
activation of caspase-2 (Shin et al., 2005). Interestingly, the 
loss of S157 phosphorylation results in the autoactivation of 
caspase-2 in a PIDDosome-independent manner, raising the 
possibility that caspase-2 activation is persistently suppressed 
by constitutively active CK2 (Shin et al., 2005). CaMKII-medi-
ated phosphorylation of caspase-2 at serine 135 (S135) was 
identified using extracts from eggs of the frog Xenopus laevis, 
where this phosphorylation can suppress the binding of RAIDD 
to caspase-2 and subsequent caspase-2 activation (Nutt et al., 
2005). As the egg extracts progressively deplete their nutrient 
reserves over time, phosphorylation of S135 is diminished and 
the extracts finally undergo “apoptosis,” as characterized by 
cytochrome c release from the mitochondria and caspase-3 
activation. These biochemical events of apoptosis can be fore-
stalled by either stimulation of the pentose phosphate pathway 
or addition of NADPH, a product of the pentose phosphatase 
pathway, to the extracts. This indicates that CaMKII-mediated 
phosphorylation of S135 is metabolically regulated (Nutt et al., 
2005). Furthermore, a recent study has shown that phosphory-
lation at the S135 site is antagonized by protein phosphatase 1 
(PP1) (Nutt et al., 2009). Of note, a region homologous to S135 
and its flanking residues appears to be conserved in mam-
malian caspase-2, including that of humans. Thus, it is pos-
sible that phosphorylation of caspase-2 may be an evolution-
arily conserved means to link the metabolic status of the cell 
to cell death pathways, although this remains to be validated. 
Interestingly, mouse caspase-2 appears to be critical for the 
death of oocytes, whose viability also likely depends on their own nutrient reserves. This raises the possibility that the over-
all regulatory mechanisms linking caspase-2 and metabolism 
through the action of modulatory kinases are also conserved 
(Bergeron et al., 1998).
Very recently, it was shown that in response to sublethal lev-
els of DNA damage, caspase-2 can be directly activated by 
phosphorylation at serine 122 (S122; officially S139 in the most 
updated protein sequence of caspase-2) by DNA-PK and that 
this phosphorylation mediates cell-cycle arrest (via the DNA 
damage checkpoint) rather than apoptosis (Shi et al., 2009). 
Interestingly, procaspase-2 forms an intranuclear complex 
with PIDD through the catalytic subunit of DNA-PK (DNA-
PKcs) without the involvement of RAIDD, a characteristic of the 
 PIDDosome (Shi et al., 2009). This finding was the first demon-
stration of a nonapoptotic role for caspase-2. Further identifi-
cation of a nuclear substrate that is cleaved by caspase-2 to 
signal the DNA damage response will be of great interest.
Caspase-8
Several studies have documented the regulation of caspase-8 
activity by tyrosine phosphorylation, rather than serine/theo-
nine phosphorylation. The Src family tyrosine kinases Src, 
Fyn, and Lyn phosphorylate tyrosine 380 (Y380) (for the A iso-
form of caspase-8, Y397 is phosphorylated; Jia et al., 2008) 
and suppress caspase-8 activation (Cursi et al., 2006; Senft 
et al., 2007). Phosphorylation of Y380 inhibits Fas-induced 
caspase-8 activation and mediates antiapoptotic signaling in 
EGF-stimulated cells or colon cancer cells (Cursi et al., 2006), 
providing a means by which these kinases that are widely impli-
cated in carcinogenesis might block apoptosis via the extrinsic 
pathway. In addition to Y380, Lyn was also found to phospho-
rylate Y465, thus inhibiting caspase activity (Jia et al., 2008). 
Importantly, Src-homology domain 2 (SH2)-containing tyrosine 
phosphatase 1 (SHP1) binds to a consensus motif (tyrosine 
310-glutamatic acid-isoleucine leucine; Y310EIL) located in the 
large subunit of caspase-8 upon phosphorylation of Y310 and 
dephosphorylates both of these tyrosine residues.
In addition to its apoptotic role, caspase-8 has also been 
implicated in regulation of cell migration and adhesion, as the 
loss of caspase-8 leads to reduced cellular motility (Helfer et 
al., 2006). Recent studies have suggested that Y380 phospho-
rylation targets caspase-8 to membrane ruffles where it func-
tions as a scaffold in a manner that does not require enzy-
matic activity (Senft et al., 2007; Barbero et al., 2008). Given its 
ability to prevent apoptosis and support cell migration, Y380 
phosphorylation may play an important role in modulating cas-
pase-8 function in embryonic development and cancer pro-
gression.
Caspase-3
Although control of the onset of apoptosis is often exerted at 
the level of the initiator caspases, a number of signaling path-
ways interrupt instead the transmission of the apoptotic signal 
through direct inhibition of effector caspases. For example, p38 
MAPK phosphorylates caspase-3 and suppresses its activity 
(Alvarado-Kristensson et al., 2004). Of note, the phosphoryla-
tion site serine 150 (S150), located within the large subunit of 
caspase-3, is conserved in other initiator and effector caspases 
(caspase-1, -2, -4, -5, -7, -8, and -9); p38 MAPK is also known 
to phosphorylate caspase-8 at serine 364 (S364) (Alvarado-Cell 138, September 4, 2009 ©2009 Elsevier Inc. 841
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association of protein phosphatase 2A 
(PP2A) with caspase-3 has been shown 
to counteract the effect of p38 MAPK 
by dephosphorylating S150, suggest-
ing that activation of PP2A may be a key 
point of caspase-3 regulation (Alvarado-
Kristensson and Andersson, 2005). The 
means of targeting PP2A to this site is 
unknown. Caspase-3 is also a target of 
PKCδ. Phosphorylation of caspase-3 
by this kinase has been shown to result 
in enhancement of its proteolytic activ-
ity, though the phosphorylation site has 
not been identified (Voss et al., 2005). 
Importantly, both the PP2A Aα subunit 
and PKCδ are known substrates of cas-
pase-3. Caspase-3-mediated cleavage 
of either enzyme elevates their activity, 
providing the opportunity for positive 
feedback in the pathway to amplify cas-
pase-3 activation and bolster transmis-
sion of the apoptotic signal (see below).
Amplifying Apoptotic Signals by 
Caspase Cleavage
There are multiple examples in which 
kinases and phosphatases—such as 
PKCδ and PP2A—are activated by cas-
pase cleavage to enhance the cell death 
process. Such activation can result from 
separation of catalytic and inhibitory 
domains by the cleavage event, subcellu-
lar relocalization of the cleaved products, 
and/or altered substrate preferences after 
proteolytic cleavage. Although simple in 
principle, for caspase cleavage to pro-
duce protein fragments that are function-
ally competent, these cleavage fragments 
must retain the ability to fold properly into 
Figure 2. Caspase Cleavage Sites
Many kinases and phosphatases are subject to 
proteolytic cleavage by caspases. Kinase/phos-
phatase domains and other regulatory regions 
of these enzymes are shown with their caspase-
mediated cleavage sites (↓) and the effects of 
caspase cleavage on their catalytic activity (ac-
tivation or inactivation). FERM, the band 4.1 ho-
mology and ERM domain; FAT, focal adhesion 
targeting region; PH, pleckstrin homology domain; 
DD, death domain; PSD, pseudosubstrate do-
main; NLS, nuclear localization signal; RBD, Rho-
binding domain; PBD, p21-binding domain; AIR, 
autoinhibitory region; NES, nuclear export signal; 
DiD, dimerization domain; PR, proline-rich region; 
CH, citron homology domain; TM, transmembrane 
domain; SH2, src homology 2 domain; SH3, src 
homology 3 domain; DNA BD, DNA-binding do-
main; Actin BD, actin-binding domain; E3BD, E3 
ligase-binding domain.
an active conformation, be susceptible to any posttranslational 
modifications required for catalytic activity, and be refractory to 
further degradation (by the proteasome, for example). Surpris-
ingly, based on a recent proteomic study, a substantial fraction 
(?35%) of random protein fragments generated by the prote-
olytic activity of caspases display marked stability (Dix et al., 
2008). Indeed, there are instances where the cleavage products 
are more stable than the full-length proteins from which they 
were derived (for example, Cdc25A, see below). In addition, cas-
pase-mediated cleavage frequently occurs within a linker region 
between two structural domains of a protein, thereby producing 
two intact (or nearly intact) domains (Dix et al., 2008). These find-
ings are consistent with the idea that some of the cleaved prod-
ucts may be functionally stable. Here, we describe a number of 
notable examples of kinase or phosphatase regulation by cas-
pase cleavage (Figure 2; for the full list of caspase substrates, 
see Tables S1–S3 available online).
Protein Kinase C
Proteins of the protein kinase C (PKC) family are lipid-activated 
serine/threonine protein kinases that modulate multiple cellu-
lar processes governing cell proliferation, differentiation, and 
apoptosis (Griner and Kazanietz, 2007). Structurally, all PKC 
isoforms consist of an N-terminal regulatory domain and a 
C-terminal kinase domain that are connected by a hinge region 
susceptible to caspase-mediated proteolytic cleavage (Figure 
2). PKC proteins reportedly cleaved by caspase-3 include the 
δ, ε, ζ, θ, η, and µ isoforms (see Table S1). Such proteolytic 
cleavage separates the kinase and autoinhibitory domains, 
potentially resulting in the generation of constitutively active 
kinase fragments.
Since the first observation of caspase-mediated activation of 
ubiquitously expressed PKCδ (Emoto et al., 1995), the roles and 
functions of this kinase have been the most extensively studied 
of all PKC isoforms. Caspase-3 prote-
olytically cleaves PKCδ at different sites 
in the mouse and human PKC isoform 
(DILD327↓N in mouse and DMQD329↓N in 
human, where ↓ indicates the cleavage 
site in the amino acid sequence). This 
cleavage generates an active 40 kDa 
kinase fragment in response to various 
apoptotic stimuli, including DNA-dam-
aging agents (Emoto et al., 1995; Ghayur et al., 1996; DeVr-
ies et al., 2002). Human PKCδ has also been demonstrated to 
be a target of caspase-2, which has only a few documented 
substrates (Panaretakis et al., 2005). Notably, ectopic expres-
sion of the catalytic fragment of PKCδ is sufficient to cause 
apoptosis, whereas the expression of catalytically inactive or 
cleavage-resistant mutant forms of the protein markedly atten-
uate or delay cell death that is triggered by genotoxic agents. 
These observations support a role for proteolytically activated 
PKCδ in the dismantling of the cell during apoptotic execution 
(Ghayur et al., 1996; DeVries et al., 2002; D’Costa and Denning, 
2005; DeVries-Seimon et al., 2007). Because PKCδ possesses 
membrane-targeting motifs at the N terminus and a nuclear 
localization signal (NLS) at the C terminus, the kinase fragment 
liberated by caspase cleavage translocates to the nucleus 
(DeVries et al., 2002), where it phosphorylates several proteins, 
including lamin B, DNA-PK, p53, p73β, and Rad9 (Griner and 
Kazanietz, 2007) (Figure 3). Although it is not known which of 
the nuclear substrates are the most significant PKCδ apoptotic 
effectors, it has been demonstrated that nuclear accumulation 
of PKCδ is critical for induction of apoptosis. Disruption of the 
NLS abolishes apoptosis that is triggered by overexpression 
of the C-terminal kinase fragment, whereas nuclear retention 
of full-length PKCδ can cause apoptosis (DeVries-Seimon et 
al., 2007). However, recent studies have also shown that both 
tyrosine phosphorylation (tyrosines 64 and 155) and the cata-
lytic activity of PKCδ also regulate PKCδ nuclear targeting, indi-
cating that caspase-mediated cleavage may not be sufficient 
to support nuclear accumulation of PKCδ (DeVries-Seimon et 
al., 2007; Humphries et al., 2008). The caspase-cleaved PKCδ 
fragment also translocates to the mitochondria, where it phos-
phorylates and targets the antiapoptotic Bcl-2 family protein 
Mcl-1 for proteolytic degradation (D’Costa and Denning, 2005; 
Figure 3. Caspase-Mediated Activation of 
Kinases Promotes Apoptosis
Caspase cleavage induces the constitutive activa-
tion of a kinase by removing an inhibitory domain 
(for example, PKCδ, ROCK1, PAK2, MST1, HPK1, 
and MEKK1) and/or triggering the redistribution of 
a cleaved kinase domain due to the loss or gain of 
a targeting motif in the cleaved protein (for exam-
ple, PKCδ, PAK2, MST1, ErbB2, and Abl). In some 
cases, caspase cleavage generates a fragment that 
does not contain a kinase domain and acts as a 
dominant negative (HPK1) or gains a new function 
(ErbB2). Caspase cleavage products may acquire 
new substrates (or binding partners) or phosphory-
late the same substrates with aberrantly high kinase 
activity, resulting in activation or inactivation of pro- 
or antiapoptotic signaling pathways.Cell 138, September 4, 2009 ©2009 Elsevier Inc. 843
Sitailo et al., 2006) (Figure 3). Importantly, studies using PKCδ 
knockout mice demonstrated that the resistance of PKCδ−/− 
cells to a wide range of proapoptotic stimuli is partly due to the 
suppression of mitochondrial cytochrome c release. This raises 
the possibility that in addition to phosphorylation of nuclear 
substrates, the cleaved PKCδ may also directly modulate mito-
chondrial membrane permeability by phosphorylating another 
substrate such as Mcl-1 (Leitges et al., 2001; Humphries et al., 
2006). Finally, it was reported that caspase-cleaved, but not 
full-length PKCδ, phosphorylates 14-3-3 proteins in a sphin-
gosine-dependent manner, which may result in the dissocia-
tion of 14-3-3 from its targets such as FOXO (forkhead box 
o) proteins (see below). Because 14-3-3 binding can activate 
the PKCε isoform, phosphorylation of 14-3-3 by cleaved PKCδ 
may result in cross-talk between PKC isoforms, decreasing 
the susceptibility of PKCε to activation (Saurin et al., 2008). In 
contrast, phosphatidylserine, an activator of full-length PKCδ, 
inhibits the catalytic activity of cleaved PKCδ, suggesting that 
proteolytic cleavage may also affect susceptibility of PKCδ to 
specific modulators (Hamaguchi et al., 2003).
ROCK1
The serine/threonine kinase Rho associated kinase-1 (ROCK1) 
is a widely expressed effector of the Rho GTPases Rho, Rac, 
and Cdc42. ROCK1 regulates actin cytoskeleton reorganiza-
tion, cell contractility, and motility through phosphorylation of 
various cytoskeletal proteins, including the myosin light chain 
(MLC). Caspase-mediated activation of ROCK1, but not its 
related isoform ROCK2, is required for the membrane blebbing 
that is typically observed in cells undergoing apoptosis (Cole-
man et al., 2001; Sebbagh et al., 2001). Accordingly, a phar-
macological ROCK1 inhibitor or the expression of a dominant 
negative ROCK1 mutant protein prevents membrane bleb-
bing (Coleman et al., 2001; Sebbagh et al., 2001). Caspase-3 
cleaves (DETD1113↓G) and separates ROCK1 into an N-terminal 
kinase domain and a C-terminal autoinhibitory region (Figure 
2). Thus, the proteolytic activity of caspase-3 generates a con-
stitutively active kinase fragment that does not require Rho 
for its activation. During Fas-induced apoptosis, robust phos-
phorylation of MLC is observed independently of Rho activity 
and is correlated with ROCK1 cleavage. This phosphorylation 
is blocked by a ROCK1 inhibitor, suggesting that the aberrant 
kinase activity of the C-terminal ROCK1 fragment causes dys-
regulated cell contractility through hyperphosphorylation of 
MLC (Sebbagh et al., 2001). Interestingly, when pretreated with 
a ROCK1 inhibitor, Fas- (or TNFα-) stimulated cells still undergo 
normal apoptosis. However, this apoptotic cell death is accom-
panied by caspase activation and chromatin condensation but 
not by membrane blebbing (Coleman et al., 2001; Sebbagh et 
al., 2001), illustrating the linkage of a single event in apoptotic 
progression to a specific caspase cleavage product.
PAK2
Mammalian homologs of the budding yeast Ste20 (Sterile 20) 
serine/threonine kinases can be divided into two subfamilies: 
p21-activated protein kinases (PAKs) and germinal center 
kinases (GCKs). Like ROCK1, PAK2 is widely expressed and 
is activated by the Rho GTPases Rac and Cdc42 to regulate 
cytoskeletal reorganization. Also similar to ROCK1, the PAK2 
kinase has an N-terminal regulatory domain that contains a 844 Cell 138, September 4, 2009 ©2009 Elsevier Inc.GTPase binding domain and a C-terminal catalytic domain 
(Figure 2). Two early studies independently demonstrated 
that PAK2, but not other PAK isoforms, undergoes apoptotic 
caspase-mediated proteolytic cleavage between the regula-
tory and catalytic domains (SHVD212↓G) to release an active 
catalytic fragment (Lee et al., 1997; Rudel and Bokoch, 1997). 
Ectopic expression or microinjection of the catalytic fragment 
of PAK2, but not full-length PAK2, triggers morphological 
manifestations of apoptosis (including cell rounding, mem-
brane blebbing, and chromatin condensation) independently 
of mitochondrial cytochrome c release and caspase activation 
(Lee et al., 1997; Vilas et al., 2006). Conversely, expression of a 
catalytically inactive mutant of this fragment markedly delays 
the apoptotic morphological changes induced by Fas stimula-
tion (Lee et al., 1997; Rudel and Bokoch, 1997). Together, these 
results strongly suggest that caspase-mediated activation of 
PAK2 regulates a signaling pathway that contributes to the dis-
mantling of the cell.
Direct substrates of caspase-activated PAK2 remain to be 
identified. It should be noted that like ROCK1, which phospho-
rylates MLC at threonine 18 (T18) and serine 19 (S19), PAK2 
can also phosphorylate MLC at S19 under nonapoptotic con-
ditions, raising the possibility that caspase-activated PAK2 
might trigger the same pathway as cleaved ROCK1 (Chew et 
al., 1998; Croft et al., 2005). That said, a constitutively active 
mutant version of the full-length PAK2 protein does not cause 
membrane blebbing in the presence of a caspase inhibitor, 
whereas a cleaved fragment of ROCK1 does (Coleman et al., 
2001). Whether this represents different signaling properties 
of PAK2 and ROCK1 or distinct biological activities of cleaved 
and full-length PAK2 is unclear. Moreover, activation of the 
c-Jun N-terminal kinase (JNK) is also observed upon expres-
sion of the PAK2 catalytic fragment, suggesting that caspase-
cleaved PAK2 may phosphorylate key targets other than MLC 
to promote apoptotic alterations in cell morphology (Vilas et al., 
2006). Interestingly, full-length PAK2 is found in the cytoplasm, 
whereas the caspase-cleaved PAK2 kinase fragment translo-
cates to the nucleus due to loss of an N-terminal nuclear export 
signal (NES) and the presence of a C-terminal NLS (Jakobi et 
al., 2003). This nuclear translocation may account, at least in 
part, for the chromatin condensation induced by the catalytic 
fragment of PAK2. In addition, another study has shown that 
caspase-cleaved PAK2 undergoes posttranslational myris-
toylation at the caspase-cleavage site, targeting the fragment 
to the plasma membrane and membrane ruffles (Vilas et al., 
2006). As full-length PAK2 does not appear to promote apop-
tosis but rather supports cell survival in some settings (Jakobi 
et al., 2001), it would be interesting to determine how caspase-
activated PAK2 and active full-length PAK2 trigger distinct sig-
naling cascades.
MST Kinases
The serine/threonine MST (mammalian Ste20-related) kinases 
are mammalian homologs of Ste20 kinases and the Drosophila 
kinase Hippo, and belong to the GCK subfamily (and thus, 
are distantly related to PAK2). MST kinases are ubiquitously 
expressed in a wide variety of tissues and are involved in the 
regulation of diverse cellular functions including morphogen-
esis, cell migration, proliferation, and apoptosis. In an early 
study, it was observed that the induction of apoptosis by vari-
ous proapoptotic stimuli is accompanied by the activation of a 
36 kDa kinase that phosphorylates myelin basic protein (MBP) 
in vitro but is distinct from caspase-cleaved PKCδ (Lu et al., 
1996). This kinase was biochemically purified and identified 
as a catalytic fragment of MST1 (Lee et al., 1998). Later stud-
ies have demonstrated that MST2 and MST3 are also prote-
olytically activated by caspase-3 in response to a variety of 
proapoptotic stimuli (Table S1). In healthy cells, intrinsic MST 
kinase activity is regulated, at least in part, by dimerization and 
phosphorylation. However, caspase-mediated cleavage mark-
edly increases activity of the MST kinase by ?10-fold and also 
causes translocation of the cleaved kinase fragment to the 
nucleus (Creasy et al., 1996; Lee et al., 2001). Like the other 
kinases described above, MST kinases consist of an N-termi-
nal kinase domain and C-terminal regulatory domain. Though 
unique to the MST kinases, the regulatory domain contains 
both a dimerization motif and two NESs (Figure 2). Two cleav-
age sites in MST1 (DEMD326↓S, TMTD349↓G) and one cleavage 
site in MST2 (DELD322↓S) and MST3 (AETD313↓G) have been 
documented (Table S1). Importantly, all of the cleavage sites 
in MST kinases are located between the catalytic and regula-
tory domains (Figure 2). Thus, in a familiar paradigm, caspase-
mediated cleavage results in removal of the regulatory domain 
and subsequent translocation of the constitutively active cata-
lytic fragment to the nucleus (Lee et al., 2001) (Figure 3).
Proapoptotic functions of MST1 and MST2 have long been 
recognized, although their physiological cellular substrates 
and signaling cascades are only now being elucidated. Over-
expression of MST1 or its N-terminal catalytic fragment alone 
induces cell rounding and chromatin condensation in many cell 
types. Overexpression of catalytically inactive mutants or RNA 
interference (RNAi)-mediated knockdown of MST1 inhibits 
the apoptotic morphology that is induced by prodeath stimuli, 
such as staurosporine or etoposide treatment (Ura et al., 2001; 
Wong et al., 2008). As with yeast Ste20, which activates the 
yeast MAPK cascade by phosphorylating yeast MAPK kinase 
kinase Ste11, MST1 and MST2 (but not MST3) are known to 
activate the JNK and p38 MAPK pathways (Graves et al., 1998; 
Song and Lee, 2008). Recently, it has been demonstrated that 
MST1-induced apoptosis can be suppressed by expression of 
a dominant-negative mutant version of JNK or by knockdown 
of either mitogen-activate protein kinase kinase 4 (MKK4) or 
MKK7, the two direct activators of JNK. This suggests that JNK 
activation may be required for the apoptotic effects of MST1 
(Ura et al. 2001; 2007). Interestingly, several lines of evidence 
suggest that chromosome condensation and DNA fragmenta-
tion, the most prominent morphological manifestations of early 
and late apoptosis, respectively, are, at least in part, mediated 
by MST1 and JNK activation (Ura et al., 2007). In response to 
DNA damage, JNK phosphorylates histone H2AX at serine 139 
(S139), thus promoting DNA fragmentation by caspase-acti-
vated DNase (CAD) (Lu et al., 2006). Other groups have also 
shown that chromosome condensation during early apopto-
sis is triggered by phosphorylation of histone H2B at serine 14 
(S14) by caspase-activated MST1 (Cheung et al., 2003; Wong 
et al., 2008) (Figure 3). A recent study has demonstrated that 
phosphorylation of histone H2B by MST1 sequesters RCC1, a guanine nucleotide exchange factor for Ran, onto the chromo-
somes, resulting in a significant decrease in levels of nuclear 
RanGTP and consequently impairing nuclear import of pro-
teins. Impaired import of nuclear factor-kappa B (NFκB), for 
example, would be expected to accelerate apoptosis (Wong 
et al., 2008).
The FOXO transcription factors induce expression of 
proapoptotic proteins such as Fas ligand and the BH3-only 
protein Bim. Akt phosphorylation of FOXO proteins promotes 
their binding to 14-3-3 proteins, thereby sequestering the tran-
scription factors in the cytoplasm (for review, see Huang and 
Tindall, 2007). Importantly, this effect appears to be counter-
acted by MST kinases. Upon oxidative stress in primary neu-
rons, MST1 phosphorylates FOXO3 at serine 207 (S207), lead-
ing to dissociation of the 14-3-3 protein and allowing FOXO3 to 
translocate to the nucleus (Lehtinen et al., 2006). Interestingly, 
recent evidence shows that MST and Akt also directly interact 
and suppress each other. Akt1 directly phosphorylates MST1 
at threonine 387 (T387), preventing the caspase-mediated acti-
vation of MST1 (Jang et al., 2007). On the other hand, activation 
by caspase-mediated cleavage allows MST1 to impede Akt1 
kinase activity (Cinar et al., 2007), suggesting that proapoptotic 
MST1 and prosurvival Akt1 create a negative feedback loop 
(Figure 3).
HPK1
Hematopoietic progenitor kinase 1 (HPK1) is a hematopoietic-
specific Ste20 homolog that participates in the proliferation 
and differentiation of hematopoietic cells. After growth factor 
stimulation or T cell or B cell receptor engagement, HPK1 turns 
on the JNK pathway through activation of MAPKKKs such as 
MEKK1 (Chen et al., 1999; Schulze-Luehrmann et al., 2002). It 
has been shown that, independently of JNK activation, HPK1 
also stimulates NF-κB signaling through phosphorylation and 
activation of IκB kinases (IKKs) (Arnold et al., 2001). HPK1 is 
composed of an N-terminal kinase domain and a C-terminal 
regulatory domain connected via a proline-rich hinge region. As 
with MST kinases, cleavage by caspase-3 at the hinge region 
(DDVD385↓I) separates these domains of HPK1, resulting in 
kinase activation (Chen et al., 1999; Arnold et al., 2001) (Figure 
2). Importantly, the cleaved catalytic fragment is still capable of 
activating the JNK pathway, but not NF-κB signaling (Chen et 
al., 1999; Arnold et al., 2001; Schulze-Luehrmann et al., 2002). 
Recent studies have demonstrated that caspase-mediated 
cleavage of HPK1 plays a role in the elimination of autoreactive 
T- and B-lymphocytes—a process termed activation-induced 
cell death (AICD)—by suppressing the NF-κB pathway; AICD-
resistant cells retain intact HPK1 and are activated for NF-κB 
signaling (Brenner et al., 2005, 2007). Interestingly, activation 
of T and B cells causes an increase in caspase-3 activity that 
may result in HPK1 cleavage but not apoptosis (Brenner et 
al., 2007). Cleavage of HPK1 by an increase in nonapoptotic 
caspase-3 activity has also been reported during monocytic 
differentiation. In contrast to lymphoid cells, the resulting 
N-terminal cleaved product supports myeloid cell survival and 
differentiation through sustained activation of the JNK path-
way (Arnold et al., 2007). These examples represent intriguing 
instances of kinase signaling that are induced by nonapoptotic 
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basal caspase-3 activity increases within certain limits to avoid 
apoptotic induction and to identify the means by which HPK1 
cleavage can induce different phenotypic outcomes in various 
cell types.
MEKK1
As mentioned above, apoptosis is frequently associated with 
JNK activation. However, the mechanism of JNK activation in 
response to apoptotic stimuli remains controversial. It appears 
that under certain circumstances, JNK is activated as a conse-
quence of caspase activation, whereas in other instances, JNK 
is stimulated independently of caspase activity. In either case, 
JNK activation may amplify proapoptotic signaling by phos-
phorylating transcription factors (for example, c-Jun) and other 
signaling factors (for example, histone H2AX, 14-3-3, Bcl-2 fam-
ily proteins) (for review, see Dhanasekaran and Reddy, 2008). 
PAK2, MST kinases, and HPK1 can activate the JNK pathway 
and, most importantly, can be also activated by caspases (this 
at least partially accounts for caspase-mediated JNK activa-
tion discussed above). MEKK1, one of the MAPKKKs, is also a 
direct substrate of caspase-3. MEKK1 cleavage by caspase-3 
appears to be activated during anoikis, Fas stimulation, and 
DNA damage (Cardone et al., 1997; Deak et al., 1998; Wid-
mann et al., 1998). MEKK1 is composed of a large N-terminal 
regulatory domain and a C-terminal kinase domain. Caspase-
mediated cleavage (DTVD874↓G in mouse) liberates a constitu-
tively active MEKK1 catalytic domain from a detergent-insolu-
ble cellular compartment into the soluble cytoplasm (Deak et 
al., 1998). Overexpression of wild-type MEKK1 or the cleaved 
catalytic fragment promotes apoptotic DNA fragmentation, 
whereas a cleavage-deficient MEKK1 mutant fails to do so 
(Widmann et al., 1998). Moreover, overexpression of cleavage-
resistant MEKK1 protects cells from anoikis-induced apopto-
sis, suggesting that caspase-mediated activation of MEKK1 
promotes apoptosis (Cardone et al., 1997). Of note, although 
initial studies of caspase-mediated cleavage of MEKK1 were 
conducted exclusively with mouse MEKK1 protein, the putative 
cleavage site in MEKK1 is also conserved in the human protein 
(DTLD878↓G), and studies have shown that caspase-mediated 
activation of MEKK1 indeed occurs in human cells (Deak et al., 
1998; Widmann et al., 1998). MEKK1 is also known to activate 
Erk and NF-κB, and it remains to be determined how caspase-
cleaved and translocated MEKK1 compares to its full-length 
counterpart in phosphorylating downstream targets.
Tyrosine Kinases
Receptor tyrosine kinases are a family of cell surface receptors 
composed of an extracellular ligand-binding domain, a trans-
membrane domain, and an intracellular tyrosine kinase domain. 
Upon engagement of their cognate ligands, the receptors 
dimerize and transmit an array of prosurvival signals through 
direct phosphorylation of cytoplasmic targets and through 
docking of various signaling proteins. To date, several receptor 
tyrosine kinases, including the rearranged during transfection 
(RET) receptor, MET kinase, anaplastic lymphoma kinase (ALK), 
epidermal growth factor receptor (EGFR), v-erb-b2 erythro-
blastic leukemia viral oncogene homolog 2 (ErbB2; also known 
as Her2/neu), and potentially the platelet-derived growth factor 
receptor (PDGFR) have been reported as substrates of multiple 
caspases (see Table S1). Caspase-mediated cleavage of the 846 Cell 138, September 4, 2009 ©2009 Elsevier Inc.receptor tyrosine kinases proteolytically removes the cytoplas-
mic region, thereby abrogating ligand-induced transmission of 
extracellular stimuli to downstream signaling molecules. How-
ever, the resulting tyrosine kinase cleavage product itself often 
has proapoptotic activity once liberated into the cytoplasm 
from the cell surface. Conversely, overexpression of cleavage-
deficient mutant receptor tyrosine kinases can delay the onset 
of apoptosis.
The MET tyrosine kinase is a scatter factor/hepatocyte 
growth factor (SF/HGF) receptor that promotes cell motility, 
invasion, and angiogenesis (Bottaro et al., 1991). The caspase-
cleaved (ESVD1000↓Y and DNID1374↓G in mouse) MET fragment 
contains its complete kinase domain, similar to the caspase-
activated serine/threonine kinases described above (Foveau 
et al., 2007) (Figure 2). Although kinase activity is required 
for apoptotic induction by the MET fragment, it remains to be 
determined how the liberated kinase domain induces amplifi-
cation of apoptotic signaling cascades (Tulasne et al., 2004). 
The extracellular domain of the MET kinase, anchored to the 
plasma membrane, is capable of binding HGF even after cas-
pase-mediated removal of the cytoplasmic region, suggesting 
that it could potentially act as a “decoy receptor” (Deheun-
inck et al., 2008). In contrast to the MET kinase, the caspase 
cleavage products reported for other receptor tyrosine kinases 
do not contain intact kinase domains, suggesting that the 
proapoptotic effects of these fragments may be independent 
of tyrosine kinase activity. Rather, the cleavage products may 
recruit or sequester other apoptotic signaling proteins. ErbB2 
may be one example. ErbB2 is cleaved by multiple caspases 
and its overexpression is associated with aggressive breast 
cancer. Recently, it was reported that ErbB2 contains a BH3-
like sequence (1120LPSETD1125) at its cytoplasmic tail and that 
caspase cleavage products spanning this region translocate 
to the mitochondria to neutralize Bcl-XL and to promote mito-
chondrial cytochrome c release (Strohecker et al., 2008) (Fig-
ure 2). Mutation of the conserved leucine 1120 and/or aspartic 
acid 1125 to glutamic acid or the overexpression of caspase 
cleavage-deficient mutant proteins markedly attenuates apop-
totic cell death in comparison to cells overexpressing wild-
type ErbB2. This further supports a proapoptotic role for the 
ErbB2 fragment (Strohecker et al., 2008). Of note, this BH3-
like sequence is also conserved in ErbB4, another member of 
the EGFR family that shares 58% overall similarity with ErbB2 
(Naresh et al., 2006). It will be interesting to determine whether 
the BH3-like sequence and the caspase-mediated releasing 
mechanism are also shared with other growth factor recep-
tors, especially PDGFR and EGFR, as these are also known 
caspase substrates (Table S1).
In addition to receptor tyrosine kinases, nonreceptor tyrosine 
kinases Etk, c-Abl, Fyn, and Lyn are subject to caspase-me-
diated cleavage in cells undergoing apoptosis (see Table S1). 
c-Abl is cleaved by caspases at multiple locations, leaving the 
kinase domain intact (Figure 2). Interestingly, a recent study 
demonstrated that cleavage of c-Abl at SLVD958↓A triggers 
nuclear translocation of a fragment containing the catalytic 
domain (Barilà et al., 2003) (Figure 3). It has been reported 
that nuclear localization of full-length c-Abl is critical for DNA 
damage-induced apoptosis, whereas its cytoplasmic retention 
can support cell survival, as in the case of the oncogenic Bcr-
Abl kinase, a fusion protein of Bcr and c-Abl found in chronic 
myelogenous leukemia (Yoshida et al., 2005). In this regard, 
retinoblastoma protein (Rb), an inhibitor of nuclear c-Abl, is 
also a target of caspases (Jänicke et al., 1996), suggesting 
that caspase-mediated cleavage may robustly amplify the 
proapoptotic c-Abl pathway in the nucleus.
Termination of Survival Signals
For the kinases described above, cleavage-induced activa-
tion enhances their (sometimes latent) proapoptotic activity, 
helping to efficiently execute the cell death program. Caspase-
mediated cleavage may also functionally inactivate kinases, 
thereby terminating survival signals, as is true for the focal 
adhesion kinase (FAK) and Akt kinases.
FAK, a widely expressed nonreceptor tyrosine kinase that 
regulates integrin-mediated cell contact with the extracellular 
matrix through the assembly of focal adhesions, was one of 
the first kinases identified as a caspase substrate (Crouch et 
al., 1996; Wen et al., 1997). Inactivation of FAK by caspases 
(VSWD704↓S, DQTD772↓S) during the early stages of apoptosis 
results in the termination of survival signals from the extracel-
lular matrix, thereby favoring apoptotic progression (Gervais et 
al., 1998b; Levkau et al., 1998a). Importantly, a caspase-gener-
ated C-terminal fragment of FAK consisting exclusively of the 
focal adhesion targeting (FAT) domain shares a high degree 
of homology with an endogenous FAK inhibitory protein FRNK 
(FAK-related nonkinase), suggesting that the C-terminal FAK 
fragment is capable of inhibiting FAK activity in a manner simi-
lar to FRNK (Gervais et al., 1998b) (Figure 2).
Similarly, the prosurvival kinase Akt is functionally inacti-
vated by caspase cleavage in response to a variety of apop-
totic stimuli, including anoikis (Bachelder et al., 2001) and 
growth factor withdrawal (Xu et al., 2002). Akt cleavage by cas-
pase-3 at multiple sites (TVAD108↓G, EEMD119↓F, ECVD462↓S; 
also see Table S1 for sites identified only in vitro) leads to inac-
tivation of the kinase by removing the membrane-targeting 
pleckstrin homology (PH) domain and/or the C-terminal hydro-
phobic motif, regions that are both critical for full activation of 
the kinase (Bachelder et al., 2001; Xu et al., 2002) (Figure 2). 
Overexpression of a Akt mutant protein unable to be cleaved 
by caspases (but not overexpression of the wild-type protein) 
markedly attenuates or delays apoptotic cell death, supporting 
a role for caspase-mediated inactivation of these prosurvival 
proteins (Bachelder et al., 2001; Xu et al., 2002).
Caspases also impede survival signaling by inactivating the 
NF-κB pathway. During apoptosis, several key components of 
the NF-κB pathway, including NF-κB itself, are targets of cas-
pases whose action can thereby terminate the transmission 
of survival signals emanating from NF-κB (Levkau et al., 1999; 
Frelin et al., 2008). In addition, caspase-mediated cleavage 
activates the NF-κB inhibitor, IκBα, further extinguishing NF-κB 
signaling (Reuther and Baldwin, 1999). Activation of NF-κB sig-
naling after stimulation by TNFα involves recruitment of the IκB 
kinase (IKK) complex to the TNF receptor through the action of 
receptor-interacting protein 1 (RIP1) kinase. Interestingly, RIP1 
cleavage by caspase-8 (LQLD324↓C) not only attenuates the 
NF-κB pathway but also activates a TNF-induced proapoptotic signaling pathway. A C-terminal noncatalytic fragment of RIP1 
containing a death domain promotes an interaction between 
TRADD (TNF receptor 1-associated death domain) and FADD, 
thereby activating the extrinsic apoptotic program (Lin et al., 
1999; Kim et al., 2000) (Figure 2). Thus, RIP1 cleavage serves 
as a molecular toggle, shutting off survival signaling while 
simultaneously activating apoptosis.
During apoptosis, the protein Smac/DIABLO is released 
from the mitochondria to the cytoplasm, where it binds IAP 
proteins, including XIAP, cIAP1, and cIAP2 (Du et al., 2000). 
Once released, Smac not only antagonizes the ability of XIAP 
to inhibit caspases but also causes the autoubiquitination and 
degradation of cIAP1 and cIAP2 (Yang and Du, 2004; Varfolom-
eev et al., 2007; Vince et al., 2007). Interestingly, RIP1 kinase 
activity has been found to be required for TNFα-mediated 
apoptosis when induced by a Smac mimetic, a small molecule 
that is designed to mimic the action of Smac by binding to 
IAPs (Wang et al., 2008). As Smac mimetics trigger the deg-
radation of cIAP1 and cIAP2 associated with the TNF receptor 
signaling complex, receptor stimulation promotes activation 
of caspase-8 through the RIP1/FADD/caspase-8 complex in 
a manner dependent on RIP1 kinase activity. Likewise, RIP1 
kinase activity is also required for the induction of programmed 
necrosis occurring when activation of caspase-8 is inhibited 
after death receptor stimulation (Holler et al., 2000; Degterev 
et al., 2008). Most interestingly, antigen stimulation in the 
absence of caspase-8 results in the death of T cells by necro-
sis, which can be rescued by an inhibitor of RIP1 (Ch’en et al., 
2008), suggesting that caspase-8-mediated cleavage of RIP1 
inactivates its kinase activity in order to avert the initiation of 
the necrotic pathway. Recent studies have shown that RIP3, 
another member of the RIP kinase family, is also required for 
RIP1-dependent programmed necrosis (Cho et al., 2009; He 
et al., 2009). Like RIP1, RIP3 is also a substrate of caspase-8 
(TEMD328↓G), although the physiological consequence of its 
cleavage remains to be fully investigated (Feng et al., 2007).
Caspases and Kinases in Cell-Cycle Regulation
Regulators of cell-cycle progression, including proteins that 
govern DNA damage and spindle checkpoint pathways, are 
also subject to caspase-mediated cleavage during apoptosis. 
In earlier studies, it was shown that the DNA-PKcs undergo 
caspase-mediated cleavage and inactivation in response to 
various proapoptotic stimuli (Casciola-Rosen et al., 1995; Song 
et al., 1996). Several additional kinases/phosphatases have 
since been identified as caspase substrates (for the full list, see 
Table S2; for many other nonkinase/phosphatase modulators 
of the checkpoint/cell cycle that are targets of caspases, such 
as poly[ADP-ribose] polymerase, see Fischer et al., 2003).
In response to genotoxic or replication stress, checkpoint 
proteins are activated to halt cell-cycle progression to allow for 
DNA repair. However, if the damage is severe (or irreparable), 
apoptotic signaling pathways are engaged. Once this deci-
sion to die is made, there is no reason for the cell to expend 
energy on further DNA repair. Moreover, termination of repair 
processes may actually facilitate execution of apoptosis. 
Therefore, it is not surprising that several checkpoint and DNA 
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have been identified as caspase substrates during apoptosis 
(see Table S2). Chk1 is activated by the ataxia-telangiectasia 
mutated and Rad3-related (ATR) kinase after DNA damage or 
the stalling of replication. A recent study demonstrated that 
Chk1 cleavage by caspase-7 (SNLD299↓F, TCPD351↓H) gener-
ates an active N-terminal kinase domain separated from a 
C-terminal autoinhibitory domain and an NLS (Matsuura et al., 
2008) (Figure 2). Interestingly, overexpression of the cleaved 
catalytic domain, but not a similar fragment lacking kinase 
activity, triggered apoptotic nuclear morphology (for example, 
DNA fragmentation) that is associated with phosphorylation of 
histone H2AX at S139. As this phosphorylation of H2AX is a 
hallmark of double-stranded DNA breaks, this raises the possi-
bility that caspase-cleaved Chk1 amplifies apoptotic pathways 
by further promoting DNA damage (Matsuura et al., 2008). It 
will be interesting to determine how the dysregulated kinase 
activity of cleaved Chk1 triggers apoptotic chromatin modifica-
tions and whether caspase-activated Chk1 indeed plays a role 
in a physiological setting.
The serine/threonine kinase Cdk2 drives the transition from 
G1 to S phase by interacting with Cyclin E and Cyclin A. It 
has long been noted that apoptosis can be associated with 
an increase in cyclin-dependent kinase 2 (Cdk2) activity. In 
Xenopus embryos, caspase cleavage of Cyclin A2 was shown 
to generate a proteasome-resistant and kinase-active form of 
Cdk2/Cyclin A2 that participates in the apoptotic response to 
ionizing radiation (Finkielstein et al., 2002). Earlier studies dem-
onstrated that the Cdk inhibitors p21Cip1/Waf1 and p27Kip1 undergo 
caspase-mediated cleavage and inactivation during apopto-
sis, consequently triggering activation of Cdk2 (Gervais et al., 
1998a; Levkau et al., 1998b; Eymin et al., 1999). Another study 
reported that Wee1, which can promote inhibitory phospho-
rylation of Cdk2 (and Cdc2), is also subjected to caspase-de-
pendent inactivation (Zhou et al., 1998). Furthermore, Cdc25A 
phosphatase, an activator of Cdk2, is 
proteolytically activated by caspase-3 
during apoptosis (Mazars et al., 2008). 
Caspase-3 cleaves Cdc25A (DLLD223↓G) 
into an N-terminal regulatory domain and 
a C-terminal catalytic domain, resulting 
in enhanced phosphatase activity of the cleaved fragment (Fig-
ure 2). Moreover, because of the presence of a C-terminal NLS 
(and removal of an N-terminal NES) and the loss of targeting 
motifs for E3 ubiquitin ligase binding, the active catalytic frag-
ment becomes highly stable and is retained in the nucleus to 
induce activation of Cdk2 (Mazars et al., 2008). These studies, 
which suggest that caspases can trigger the activation of Cdk2 
through proteolytic activation of its activators and proteolytic 
inactivation of its inhibitors, support a model in which caspase 
cleavage of cell-cycle regulators may divert them from their 
duties in cell cycle control to promote apoptosis instead (Figure 
4). In this regard, it is interesting that the Cdk2 activator Cyclin 
E, which is critical for driving the G1/S transition, is also a tar-
get of caspase-mediated cleavage in cultured hematopoietic 
tumor cells during DNA damage-induced apoptosis (Mazum-
der et al., 2002). Indeed, a caspase-cleaved fragment of Cyclin 
E (Cyclin E276–395), no longer capable of interacting with Cdk2, 
has been shown to bind to and sequester the Bax-binding pro-
tein Ku70, allowing the release of Bax from the inactive Bax-
Ku70 complex and facilitating its activation (Mazumder et al., 
2007).
Kinase Modulation of Caspase Substrates
The crosstalk between kinases and caspases extends beyond 
their abilities to act directly on one another. Kinases targeted 
to potential caspase substrates may also significantly alter the 
susceptibility of substrates to cleavage. For example, MST1 
cleavage by caspases is inhibited by Akt phosphorylation at 
T387 (Jang et al., 2007). In addition, it has been shown that 
both CK1 and CK2 phosphorylate the BH3-protein Bid at thre-
onine 58 (T58), serine 61 (S61), and serine 64 (S64) in the vicin-
ity of a cleavage site (LQTD59↓G in the mouse Bid), protecting 
the protein from cleavage by caspase-8 (Desagher et al., 2001). 
It is possible that phosphorylation could also protect Bid from 
Figure 4. Increased Cdk2 Activity during 
Apoptosis
In healthy cells (left), activity of Cdk2, which forms 
a complex with Cyclin A or Cyclin E, is inhibited 
by p21Cip1/Waf1 and/or p27Kip1. Cdk2 activity is also 
regulated by inhibitory phosphorylations modulat-
ed by the Wee1 kinase and Cdc25A phosphatase. 
In cells undergoing apoptosis (right), p21Cip1/Waf1, 
p27Kip1, and Wee1 are proteolytically inactivated by 
caspases. In contrast, caspase-mediated cleav-
age of Cdc25A generates a constitutively active 
phosphatase fragment with a nuclear localization 
signal that confines the phosphatase fragment 
in the nucleus. Caspase-mediated cleavage also 
separates the active Cdc25A fragment from the 
E3 ligase-binding domains at the N-terminal half 
of the phosphatase, resulting in increased stabil-
ity of the active phosphatase fragment. Conse-
quently, caspase activation can indirectly trigger 
an increase in Cdk2 activity.848 Cell 138, September 4, 2009 ©2009 Elsevier Inc.
cleavage by caspase-2, though this has not yet been reported. 
Because Bid cleavage leads to activation of the intrinsic path-
way of apoptosis, kinases that inhibit this proteolytic cleavage 
event might well be expected to raise the threshold for apop-
tosis, making it more difficult for apoptotic stimuli to trigger 
cell death (Figure 1). Similarly, it has been reported that phos-
phorylation of the tumor suppressor PTEN (phosphatase and 
tensin homolog deleted from chromosome 10) by CK2 appears 
to protect the phosphatase from the proteolytic activity of cas-
pase-3 (Torres et al., 2003). Phospholipase C-γ1 (PLCγ1) is also 
targeted by caspase-3 and -7, but the cleavage is prevented by 
phosphorylation of tyrosine 771 (Y771) adjacent to the cleav-
age site (AEPD770↓Y) (Bae et al., 2000). IκBα is protected from 
caspase cleavage (DRHD31↓S) upon phosphorylation at serine 
32 (S32) and serine 36 (S36) by the IKK complex (Barkett et 
al., 1997). Despite these examples, the prevalence of a mecha-
nism for caspase substrate preservation by phosphorylation 
remains to be determined.
Phosphorylation can impede caspase-mediated sub-
strate cleavage, but it is also possible that phosphorylation 
can enhance caspase-mediated cleavage of substrates to 
either inhibit or promote death, depending on the nature of 
the substrate. For example, cleavage of PKCδ by caspase-3 
(DILD327↓N in mouse) is positively regulated by the Src kinase 
through phosphorylation at tyrosine 332 (Y332) (Lu et al., 2007). 
Likewise, it has been suggested that mixed lineage kinase-3 
(MLK3) phosphorylation of the Golgi structural protein golgin-
160 can enhance caspase cleavage at a site near the phos-
phorylation site (Cha et al., 2004). Phosphorylation of the Bcl-2 
family member BimEL by JNK can also promote its cleavage 
by caspase-3 (ECD13↓R), though the cleavage may be second-
ary to the phosphorylation-dependent release of BimEL from 
microtubule sequestration (Chen and Zhou, 2004; Corazza et 
al., 2006). As databases of kinase substrates/phosphorylation 
sites and caspase substrates/cleavage sites continue to grow, 
it is likely that mining these databases for common targets will 
reveal even greater crosstalk between kinases and caspases in 
the control of proteolytic cleavage of substrates.
Caspase Regulation of Phosphatases
The actions of kinases, either pro- or antiapoptotic, are coun-
terbalanced by phosphatases that can remove the phospho-
rylation from caspases or their substrates. Thus, it is perhaps 
not surprising that phosphatases too can be targets of cas-
pase cleavage, though less is known about this mechanism 
of regulation (see Table S3). Protein phosphatase 2A (PP2A), 
a ubiquitously expressed serine/threonine phosphatase that 
is involved in numerous cellular signaling pathways, is one 
example of a phosphatase caspase substrate. The PP2A 
holoenzyme consists of three subunits: the A and B regula-
tory scaffold subunits and the C catalytic subunit. Subcellu-
lar localization and substrate specificity of the PP2A holoen-
zyme are determined in part by a large number of B subunits. 
Yeast two-hybrid screening of a human lymphocyte cDNA 
library revealed that the regulatory subunit Aα of PP2A is a 
substrate of caspase-3 (Santoro et al., 1998). Cleavage of the 
Aα subunit leads to enhancement of PP2A activity in vitro and 
in vivo, suggesting that PP2A may be proteolytically activated by caspase-3 during apoptosis (Santoro et al., 1998). Interest-
ingly, the SET protein, a PP2A inhibitor, has also been recog-
nized as a caspase substrate (Morita et al., 2000), raising the 
possibility that elevated PP2A activity during apoptosis may 
also be mediated by inactivation of its inhibitors (such as SET) 
by caspases. Similarly, PP1 inhibitor-3 (I-3), which specifically 
inhibits the phosphatase activity of PP1α and PP1γ1, is inacti-
vated by caspase-3 during apoptosis, resulting in an increase 
in PP1α and PP1γ1 activity (Huang and Lee, 2008). In addition 
to controlling diverse signaling pathways, PP2A and PP1α may 
also remove inhibitory phosphorylations on caspase-3 and -9, 
respectively, and thus further contribute to apoptotic progres-
sion (Alvarado-Kristensson and Andersson, 2005; Dessauge et 
al., 2006).
Concluding Remarks
Cross-regulation of kinases/phosphatases and caspases 
allows for fine tuning of the apoptotic threshold, as well as the 
opportunity to amplify apoptotic signals through the production 
of “strategic” cleavage products. In healthy cells, caspases are 
turned off by phosphorylation-mediated suppression in addi-
tion to other mechanisms. However, once cells receive a sub-
stantial stimulus that overcomes this suppression, caspases 
are turned on to cleave kinases and phosphatases, among 
other substrates. This not only helps to turn off survival sig-
naling pathways but, in multiple cases, generates a number 
of proapoptotic protein fragments. Prosurvival kinases and 
phosphatases can be converted to fragments by proapop-
totic activity, and some proapoptotic kinase/phosphatases are 
also activated by caspases. Consequently, once the balance 
shifts toward cell death, the caspase-kinase/phosphatase net-
work amplifies apoptotic signals to efficiently dismantle the 
apoptotic cell. The potential crosstalk between caspases and 
kinases/phosphatases becomes even more elaborate when 
one considers the possibility that the kinases phosphorylat-
ing the caspases (for example, p38 MAPK) could potentially 
be activated by caspase-mediated cleavage of upstream com-
ponents in their own regulatory pathways (for example, by the 
MAPKKKs or MAPKKKKs).
When caspase activation is blocked despite the presence of 
death stimuli, nonapoptotic cell death (for example, autophagy 
and necrosis) is often observed (Kroemer et al., 2008). Several 
lines of evidence suggest that caspase-mediated activation 
of kinases and phosphatases may also counteract autophagy 
and necrosis, directing a cell death signal toward the execu-
tion of apoptosis instead. For example, a recent study dem-
onstrated that increased stability of the Cdk inhibitor p27Kip1 in 
quiescent cells promotes autophagy, whereas knockdown of 
p27Kip1 protein levels is sufficient to cause apoptosis in these 
cells (Liang et al., 2007). This suggests that if there is enough 
caspase activity to cleave p27Kip1 in the cells under nutrient-lim-
iting conditions, the cells will choose apoptosis. Likewise, the 
RIP1 kinase has been put forth as a key protein in the induction 
of programmed necrosis. As described above, death receptor-
induced necrosis requires RIP1 kinase activity, whereas kinase 
activity appears to be dispensable for activation of the NF-κB 
or apoptotic pathways (with the exception of Smac mimetic-
induced apoptosis). Upon death receptor stimulation, cleavage Cell 138, September 4, 2009 ©2009 Elsevier Inc. 849
of RIP1 by caspase-8 inactivates its kinase activity, forestalling 
programmed necrosis. The resulting noncatalytic C-terminal 
fragment of RIP1 favors the apoptotic pathway over the NF-κB 
survival pathway. Therefore, these findings place RIP1 at the 
molecular intersection of survival, apoptotic, and necrotic sig-
naling pathways. Caspase-mediated activation of kinases and 
phosphatases also explains at least some of the morphologi-
cal differences between apoptotic cell death and nonapoptotic 
cell death. Membrane blebbing and chromatin condensation, 
which can be triggered simply by caspase-mediated cleavage 
of substrates such as ROCK1 and MST1, respectively, are not 
observed in cells undergoing autophagy or necrosis.
Although a large number of caspase substrates, including 
the kinases and their regulators discussed here, have been 
identified, the temporal sequence of these cleavage events 
has not been finely resolved. Although some of the important 
signaling kinases described here are cleaved early in the apop-
totic process before cell death is even morphologically evident 
(for example, HPK1, MEKK1, ErbB2, c-Abl, p21Cip1/Waf1, p27Kip1), 
others that are cleaved at later stages of apoptosis may merely 
represent final end-products of the long proteolytic cleavage 
cascade, with negligible effects on the progression of the 
apoptotic process (even if the putative cleavage fragments 
appear to promote apoptosis upon cellular overexpression). 
Conversely, it may be that there are functional reasons for late-
stage proteolytic cleavage in the apoptotic process that we do 
not yet fully understand. In addition, with a few exceptions, the 
immediate substrates of caspase-activated kinase fragments 
still remain to be identified. Emerging proteomic technologies 
that enable identification and confirmation of caspase sub-
strates (and their cleavage sites) (Dix et al., 2008; Mahrus et al., 
2008), together with gene targeting and biochemical analyses, 
should help to unravel the molecular mechanisms underlying 
the coordination of complex cellular life and death decisions by 
the caspase-kinase/phosphatase networks.
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